![Timo Ilmari Vaara](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Timo Ilmari Vaara
Fondateur chez Northern Antibiotics Oy
Postes actifs de Timo Ilmari Vaara
Sociétés | Poste | Début | Fin |
---|---|---|---|
Northern Antibiotics Oy
![]() Northern Antibiotics Oy Pharmaceuticals: MajorHealth Technology Northern Antibiotics Oy engages in the discovery and development of novel antibiotics against multidrug-resistant gram-negative bacteria. It develops compounds, which are active against difficult-to-treat gram-negative bacteria, such as multi-resistant Escherichia coli, Klebsiella pneumoniae, other species of Enterobacteriaceae, and Acinetobacter baumannii. The company was founded by Martti Sakari Vaara and Timo Ilmari Vaara in 2003 and is headquartered in Helsinki, Finland. | Président | 01/01/2003 | - |
Fondateur | 14/04/2010 | - |
Historique de carrière de Timo Ilmari Vaara
Anciens postes connus de Timo Ilmari Vaara
Sociétés | Poste | Début | Fin |
---|---|---|---|
UniCrop Oy
![]() UniCrop Oy Pharmaceuticals: MajorHealth Technology UniCrop Oy develops sprouting technology for the production of therapeutic proteins. It develops prouting technology for the production of therapeutic proteins. It uses molecular biology technologies to develop new uses for plants. The company was founded by Kimmo Koivu and Viktor Kuvshinov in 1998 and is located in Helsinki, Finland. | President | - | - |
Alko Oy
![]() Alko Oy Specialty StoresRetail Trade Alko Oy retails alcoholic beverages. Its products include wines, spirits, beers, ciders, long drinks, and non-alcoholic beverages. The company also offers packaging materials, bottle openers, bar accessories, glasses, gift deliveries, and gift cards. Alko was founded on April 5, 1932 and is headquartered in Helsinki, Finland. | Corporate Officer/Principal | - | - |
Lymphatix Oy
![]() Lymphatix Oy Miscellaneous Commercial ServicesCommercial Services Part of Premier Veterinary Group Plc, Lymphatix Oy is a Finnish company that researches and develops therapies for vascular and circulatory system-related diseases and cancer. The company is based in Helsinki, Finland. Lymphatix was acquired by Ark Therapeutics Group Plc on January 08, 2008 for $3.31 million. | President | - | - |
Formation de Timo Ilmari Vaara
University of Helsinki | Graduate Degree |
Statistiques
Internationale
Finlande | 6 |
Opérationnelle
President | 2 |
Chairman | 1 |
Founder | 1 |
Sectorielle
Health Technology | 3 |
Retail Trade | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Alko Oy
![]() Alko Oy Specialty StoresRetail Trade Alko Oy retails alcoholic beverages. Its products include wines, spirits, beers, ciders, long drinks, and non-alcoholic beverages. The company also offers packaging materials, bottle openers, bar accessories, glasses, gift deliveries, and gift cards. Alko was founded on April 5, 1932 and is headquartered in Helsinki, Finland. | Retail Trade |
UniCrop Oy
![]() UniCrop Oy Pharmaceuticals: MajorHealth Technology UniCrop Oy develops sprouting technology for the production of therapeutic proteins. It develops prouting technology for the production of therapeutic proteins. It uses molecular biology technologies to develop new uses for plants. The company was founded by Kimmo Koivu and Viktor Kuvshinov in 1998 and is located in Helsinki, Finland. | Health Technology |
Lymphatix Oy
![]() Lymphatix Oy Miscellaneous Commercial ServicesCommercial Services Part of Premier Veterinary Group Plc, Lymphatix Oy is a Finnish company that researches and develops therapies for vascular and circulatory system-related diseases and cancer. The company is based in Helsinki, Finland. Lymphatix was acquired by Ark Therapeutics Group Plc on January 08, 2008 for $3.31 million. | Commercial Services |
Northern Antibiotics Oy
![]() Northern Antibiotics Oy Pharmaceuticals: MajorHealth Technology Northern Antibiotics Oy engages in the discovery and development of novel antibiotics against multidrug-resistant gram-negative bacteria. It develops compounds, which are active against difficult-to-treat gram-negative bacteria, such as multi-resistant Escherichia coli, Klebsiella pneumoniae, other species of Enterobacteriaceae, and Acinetobacter baumannii. The company was founded by Martti Sakari Vaara and Timo Ilmari Vaara in 2003 and is headquartered in Helsinki, Finland. | Health Technology |
- Bourse
- Insiders
- Timo Ilmari Vaara
- Expérience